Antihistamine Forced Switch Proposal Returns In Citizen Petition
This article was originally published in The Tan Sheet
Executive Summary
A law firm seeks to cut its own health care costs as well as direct FDA's attention to previous citizen petitions to switch Rx antihistamines to OTC with a petition asking FDA to switch Sanofi-Aventis's Allegra and Pfizer's Zyrtec
You may also be interested in...
Zyrtec-D Switch Approved – J&J Will Launch Behind The Counter This Year
FDA approved Johnson & Johnson's bid to switch prescription antihistamine/nasal decongestant Zyrtec-D to nonprescription status, but the firm is still awaiting a reply on single-ingredient Zyrtec